ASTEC vs MOL: Stock Comparison
Meghmani Organics Limited is the larger company by market capitalisation. Astec LifeSciences Limited shows a lower P/E and faster revenue growth, while Meghmani Organics Limited shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ASTEC leads 5; MOL leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ASTEC | MOL |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Pesticides & Agrochemicals | Pesticides & Agrochemicals |
Price
| Metric | ASTEC | MOL |
|---|---|---|
| Live Price | ₹597.25 | ₹62.51 |
| Day Change | 0.77% | -2.98% |
| Volume | 21,963 | 15.44 L |
| 52-Week High | ₹941.75 | ₹87.75 |
| 52-Week Low | ₹513.4 | ₹36.5 |
| Distance from 52W High | -36.58% | -28.76% |
Valuation
| Metric | ASTEC | MOL |
|---|---|---|
| Market Cap | ₹1,341 Cr | ₹1,587 Cr |
| P/E Ratio | -20.22x | 23.76x |
| P/B Ratio | 3.45x | 0.99x |
| EPS | ₹-29.31 | ₹1.13 |
| Book Value | ₹175.3 | ₹61.55 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ASTEC | MOL |
|---|---|---|
| Revenue Growth (TTM YoY) | 32.7% | -14.3% |
| EPS Growth (TTM YoY) | 0% | -59% |
| Qtr Sales Growth | 32.7% | -14.3% |
| Qtr Profit Growth | 51.8% | -59.5% |
Profitability & Leverage
| Metric | ASTEC | MOL |
|---|---|---|
| ROE | -25.2% | 1.88% |
| ROCE | -5.45% | 6.67% |
| Net Margin | -14.69% | 1.32% |
| Operating Margin | -1.01% | 8.12% |
| Debt to Equity | 1.15x | 0.47x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ASTEC | MOL |
|---|---|---|
| Promoter Holding | 71.96%▼ 0.01 pp | 48.95% |
| FII Holding | 0.01%▼ 0.01 pp | 0.91%▼ 0.43 pp |
| DII Holding | 3.33%▼ 0.01 pp | 0% |
| Public Holding | 24.69%▲ 0.02 pp | 50.1%▲ 0.44 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Astec LifeSciences Limited and Meghmani Organics Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.